Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spinraza
Pharma
Biogen looks to shake up SMA status quo with Spinraza HD nod
Biogen is eager to give Spinraza a boost in the market with the new FDA approval of the drug's high-dose version.
Eric Sagonowsky
Mar 30, 2026 9:58am
Biogen bets HD Spinraza can outmuscle Roche's oral rival
Feb 6, 2026 12:02pm
Biogen undeterred after FDA snub for high-dose Spinraza in SMA
Sep 24, 2025 9:51am
Roche picks up FDA nod for easier Evrysdi dosing format in SMA
Feb 12, 2025 2:30pm
Biogen reports promising results for higher dose of Spinraza
Oct 9, 2024 7:30am
Biogen to seek approval for high-dose version of Spinraza
Sep 4, 2024 11:45am
